Fresenius SE KGaA (XSWX:FRE) Receivables Turnover: 1.53 (As of Mar. 2026)


XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
71 GF Score
Price CHF36.15
GF Value CHF33.18
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Receivables Turnover?

Fresenius SE KGaA XSWX:FRE 71 Receivables Turnover is 1.53 as of Mar. 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF33.18 (Fairly Valued). The stock has 5 warning signs investors should review. Among 660 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 62.58% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Fresenius SE KGaA's Revenue for the three months ended in Mar. 2026 was CHF5,295 Mil. Fresenius SE KGaA's average Accounts Receivable for the three months ended in Mar. 2026 was CHF3,463 Mil. Hence, Fresenius SE KGaA's Receivables Turnover for the three months ended in Mar. 2026 was 1.53.


Fresenius SE KGaA  (XSWX:FRE) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Fresenius SE KGaA Receivables Turnover Related Terms


Fresenius SE KGaA Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Receivables Turnover Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.27 2.95 3.77 6.09 6.48

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.59 1.46 1.43 1.66 1.53

XSWX:FRE vs HCA, THC, DVA: Receivables Turnover Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA Receivables Turnover vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Receivables Turnover falls into.


XSWX:FRE
71GF Score
Fresenius SE & Co KGaA XSWX:FRE
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Fresenius SE KGaA's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=21343.669 / ((3267.644 + 3320.106) / 2 )
=21343.669 / 3293.875
=6.48

Fresenius SE KGaA's Receivables Turnover for the quarter that ended in Mar. 2026 is calculated as

Receivables Turnover (Q: Mar. 2026 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Mar. 2026 ) / ((Accounts Receivable (Q: Dec. 2025 ) + Accounts Receivable (Q: Mar. 2026 )) / count )
=5295.389 / ((3320.106 + 3606.107) / 2 )
=5295.389 / 3463.1065
=1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 1.53 mean?
Fresenius SE KGaA (XSWX:FRE) has a Receivables Turnover of 1.53 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Fresenius SE KGaA and its competitors. According to the industry distribution chart, Fresenius SE KGaA ranks #413 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 62.6%.
Is Fresenius SE KGaA's Receivables Turnover too high?
Fresenius SE KGaA's current Receivables Turnover is 1.53. The Healthcare Providers & Services industry median Receivables Turnover is 7.64. Fresenius SE KGaA's value of 1.53 is 80% below this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #413 out of 660 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #413 out of 660 companies for Receivables Turnover. This places Fresenius SE KGaA in the lower half of its industry. The industry median Receivables Turnover is 7.64. Fresenius SE KGaA's value of 1.53 is 80% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.64, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current Receivables Turnover of 1.53 is 80% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Receivables Turnover is 1.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF33.18, compared to a current price of CHF36.15 — trading 9% above its estimated fair value. The current Receivables Turnover is 1.53 and 80% below the Healthcare Providers & Services industry median of 7.64. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Receivables Turnover is 1.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF36.15 is trading 9% above its estimated GF Value™ of CHF33.18. GuruFocus considers Fresenius SE KGaA to be Fairly Valued.

Key valuation signals for XSWX:FRE:

  • Receivables Turnover: 1.53
  • GF Value™: CHF33.18 vs. price of CHF36.15 (9% above fair value)
  • GF Score™: 71/100 with 5 warning signs
  • Industry Position: 80% below the Healthcare Providers & Services median (#413 of 660)

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score

Get the complete analysis for XSWX:FRE

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF36.15
Price
CHF33.18
GF Value